Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 3Neuroendocrine Tumors 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Sorafenib 52pembrolizumab 26Nivolumab 20Bevacizumab 19Radiosurgery 17Doxorubicin 12atezolizumab 9Erlotinib Hydrochloride 9lenvatinib 8cabozantinib 7Magnetic Resonance Spectroscopy 7tremelimumab 6durvalumab 6Ramucirumab 6Radiofrequency Ablation 6Cisplatin 6Sunitinib 5tislelizumab 4regorafenib 4Oxaliplatin 4Leucovorin 4Ipilimumab 4Fluorouracil 4Everolimus 4Capecitabine 4nintedanib 3fluoromisonidazole 3carotuximab 3bavituximab 3Tomography, X-Ray Computed 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Carcinoma, Hepatocellular × Chemoembolization, Therapeutic × Clear all
NCT03960008 2024-08-28

SBRTvsTACE

Lahey Clinic

Phase 3 Terminated
9 enrolled 7 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT02182687 2024-03-05

SBRTvsTACE

Lahey Clinic

Phase 2 Completed
60 enrolled 12 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT02524119 2021-02-01

LEE001

University of Texas Southwestern Medical Center

Phase 2 Terminated
5 enrolled 9 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡